WallStreetZenWallStreetZen

NASDAQ: NLSP
Nls Pharmaceutics Ltd Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

NLSP earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$15.5M
Current Profit Margin
0%

NLSP Return on Equity

Current Company
N/A
Current Industry
1.3%
Current Market
-0.3%

Be the first to know when NLSP announces earnings.

NLSP Return on Assets

Current Company
-714.7%
Current Industry
-1.5%
NLSP is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

NLSP Return on Capital Employed

Current Company
947.82%
Current Industry
11.8%
NLSP has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

NLSP vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
NLSP$0.00-$15.36M-$15.47MN/AN/A
XCUR$23.79M$5.04M$3.07M+38.63%-72.96%
LGVN$709.00k-$20.47M-$22.21M-19.78%N/A
ALZN$0.00-$12.35M-$12.40MN/AN/A
SNPX$0.00-$6.03M-$13.78MN/AN/A
View Top Biotech Stocks

Nls Pharmaceutics Earnings & Revenue FAQ

What were NLSP's earnings last quarter?

Nls Pharmaceutics (NASDAQ: NLSP) reported Q2 2023 earnings per share (EPS) of N/A, up N/A year over year. Total Nls Pharmaceutics earnings for the quarter were N/A. In the same quarter last year, Nls Pharmaceutics's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Nls Pharmaceutics stock.

What was NLSP's earnings growth in the past year?

As of Q2 2024, Nls Pharmaceutics's earnings has grown year over year. Nls Pharmaceutics's earnings in the past year totalled -$15.47 million.

What was NLSP's revenue last quarter?

Nls Pharmaceutics (NASDAQ: NLSP) reported Q2 2023 revenue of N/A up N/A year over year. In the same quarter last year, Nls Pharmaceutics's revenue was N/A.

What was NLSP's revenue growth in the past year?

As of Q2 2024, Nls Pharmaceutics's revenue has grown null year over year. Nls Pharmaceutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.